<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Increased plasma free fatty acid (FFA) level is a hallmark of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the underlying molecular basis for FFA-caused <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>Here we identified plasma 5'-<z:chebi fb="3" ids="16335">adenosine</z:chebi> monophosphate (pAMP) markedly elevated in the plasma of type 2 diabetic mice </plain></SENT>
<SENT sid="3" pm="."><plain>High levels of FFAs induced damage in vein endothelial cells and contributed to an increase in pAMP </plain></SENT>
<SENT sid="4" pm="."><plain>Administration of synthetic 5'-<z:chebi fb="47" ids="16027,28971">AMP</z:chebi> caused <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and impaired insulin action in lean <z:mp ids='MP_0002169'>wild-type</z:mp> mice </plain></SENT>
<SENT sid="5" pm="."><plain>5'-<z:chebi fb="47" ids="16027,28971">AMP</z:chebi> elevated blood <z:chebi fb="105" ids="17234">glucose</z:chebi> in mice deficient in <z:chebi fb="3" ids="16335">adenosine</z:chebi> receptors with equal efficiency as <z:mp ids='MP_0002169'>wild-type</z:mp> mice </plain></SENT>
<SENT sid="6" pm="."><plain>The function of pAMP was initiated by the elevation of cellular <z:chebi fb="3" ids="16335">adenosine</z:chebi> levels, directly stimulating G-6-Pase enzyme activity, attenuating insulin-dependent GLUT4 translocation in skeletal muscle, and displaying a rapid and steep increase in blood <z:chebi fb="105" ids="17234">glucose</z:chebi> and a decrease in hepatic <z:chebi fb="15" ids="28087">glycogen</z:chebi> level </plain></SENT>
<SENT sid="7" pm="."><plain>It was followed by an increase in the gene expression of hepatic Foxo1 and its targeting gene Pepck and G6Pase, which was similar to diabetic phenotype in db/db mice </plain></SENT>
<SENT sid="8" pm="."><plain>Our results suggest that pAMP is a potential upstream regulator of <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>